Quantcast Mohamed Industry News
mohamed industry news By
mohamed industry news >> CANCER May 22, 2015 members login here
>>  CANCER
How a Common Childhood Vaccine Helps Ward Off Cancer
Time - 5/21/2015
It reduces the risk of childhood leukemia by 20% Scientists now understand why a common childhood vaccine reduces the risk of leukemia. Researchers previously knew that the vaccine against Haemophilus
     Add Comment

Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With
CNBC - 5/21/2015
Diagnostic Test Reveals Actionable Mutations; Results Returned Within 72 Hours BOULDER, Colo.--(BUSINESS WIRE)-- Biodesix, Inc. today announced the launch of GeneStrat™, a targeted liquid biopsy
Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test.. ADVFN Australia
all 1 news articles >>      Add Comment

Vermillion Approved for a $7.5 Million Grant by the Cancer Prevention and Research
Reuters - 5/21/2015
AUSTIN, Texas This planned registry differs from previous clinical trials conducted by Vermillion for its OVA1® and OVA2 (second-generation OVA1) tests in several important ways: The first output of the
     Add Comment

Tolero Pharmaceuticals to Present Alvocidib Data at the 2015 American Society of
CNBC - 5/21/2015
SALT LAKE CITY--(BUSINESS WIRE)-- Tolero Pharmaceuticals, Inc. , a clinical-stage company developing treatments for serious hematological diseases, today announced the upcoming presentation of a novel
     Add Comment

ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular
Reuters - 5/21/2015
NEW YORK ICC is a tumor in the bile duct that arises within the liver. It is the second most common primary liver tumor and represents approximately 15% of new HCC cases diagnosed annually. Surgical resection,
     Add Comment

Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto
Reuters - 5/21/2015
REDWOOD CITY, Calif. "We are very pleased with this draft coverage determination. It is an important step toward ensuring that all prostate cancer patients covered by Medicare, which represents 50 percent
     Add Comment

Karyopharm to Present Hematologic Cancer Data on Lead Drug Candidate Selinexor at
Reuters - 5/21/2015
"We are excited by these promising data to be presented at EHA, which continue to demonstrate the vast potential of selinexor across hematologic malignancies," said Sharon Shacham, PhD, MBA, President
     Add Comment

Calithera Reports Initial Phase I Data for CB-839 in Patients with Acute Leukemias
Bloomberg - 5/21/2015
(GLOBE NEWSWIRE) -- Calithera Biosciences "We are very encouraged by these early clinical data," said Susan Molineaux, PhD, President and Chief Executive Officer of Calithera. "While the primary objectives
     Add Comment

New Cancer cell line panel screening technology will better help to cure cancer
Bloomberg - 5/21/2015
America - Cancer is one of the major diseases that could threat human health and then the prevention and treatment of cancer has become one of the main objectives of the research and development of Therapeutic
     Add Comment

B Communications Reports Financial Results for the First Quarter of 2015
Bloomberg - 5/21/2015
Your requested update has been submitted Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If
Barnie’s CoffeeKitchen Gains New Grocery Chain Customer, Ingles Markets Bloomberg
ACCC will not oppose Federation Centres' proposed acquisition of Novion Property Bloomberg
all 1897 news articles >>      Add Comment

MagForce AG: MagForce USA, Inc. files Investigational Device Exemption for NanoTherm(TM)
Bloomberg - 5/21/2015
-- MagForce USA, Inc., a majority owned subsidiary of MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on
MAGFORCE : USA, Inc. files Investigational Device Exemption for NanoTherm™ Therapy 4 Traders
MagForce AG: MagForce USA, Inc. files Investigational Device Exemption for ... Ariva.de
all 3 news articles >>      Add Comment

Practicing Clinicians Exchange Launches Oncology Continuing...
San Francisco Chronicle - 5/21/2015
Live meeting series features nationally recognized oncology experts in lung cancer, breast cancer, melanoma, and more Stamford, CT USA (PRWEB) May 20, 2015 Practicing Clinicians Exchange (PCE), in
Practicing Clinicians Exchange Launches Oncology Continuing Medical Education (CME) MySanAntonio
Practicing Clinicians Exchange Launches Oncology Continuing Medical... PRWeb
all 2 news articles >>      Add Comment

FDA Grants Orphan Drug Designation to Aura Biosciences’ Novel Treatment for Uveal
A.M. Best - 5/21/2015
__
     Add Comment

Biodesix Launches GeneStrat Targeted Liquid Biopsy Mutation Test For Patients With
A.M. Best - 5/21/2015
__
     Add Comment

Two Spices Prevent Cancer: Study
NewsMax.com - 5/21/2015
A combination of extracts from two well-known spices — turmeric and frankincense — work together to prevent colon cancer. A study at Baylor University Medical Center in Dallas found that the combination
     Add Comment

CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma
A.M. Best - 5/21/2015
/PRNewswire/ --   CytRx Corporation ( NASDAQ: CYTR ), a biopharmaceutical research and development company specializing in oncology, today announced positive updated results from its ongoing Phase 2 clinical
CYTRX : Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in 4 Traders
all 1 news articles >>      Add Comment

First-line axitinib ‘feasible’ in advanced, metastatic RCC
MedWire News - 5/21/2015
medwireNews: A Japanese single-institution study suggests that axitinib may be a feasible first-line option for patients with locally advanced or metastatic renal cell carcinoma (RCC). Axitinib treatment
     Add Comment

Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2807-2813 (21 May 2015) | doi :10.1038/onc.2014.211 D J Voce ,
     Add Comment

MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through
Oncogene - 5/21/2015
M A Macha, S Rachagani, P Pai, S Gupta, W M Lydiatt, R B Smith, S L Johansson, S M Lele, S S Kakar, H Farghaly, J H Lee, J Meza, A K Ganti, M Jain and S K Batra Correction to : Oncogene (2015) 34 ,
     Add Comment

In vivo quantitative phosphoproteomic profiling identifies novel regulators of castration-resistant
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2764-2776 (21 May 2015) | doi :10.1038/onc.2014.206 N Jiang ,
     Add Comment

Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas:
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2801-2806 (21 May 2015) | doi :10.1038/onc.2014.223 J T Park ,
     Add Comment

DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2790-2800 (21 May 2015) | doi :10.1038/onc.2014.190 H-H Chen ,
     Add Comment

The Gß5 protein regulates sensitivity to TRAIL-induced cell death in colon carcinoma
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2753-2763 (21 May 2015) | doi :10.1038/onc.2014.213 D Fuchs ,
     Add Comment

DAB2IP regulates cancer stem cell phenotypes through modulating stem cell factor
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2741-2752 (21 May 2015) | doi :10.1038/onc.2014.215 E-J Yun ,
     Add Comment

Autocrine CSF1R signaling mediates switching between invasion and proliferation
Oncogene - 5/21/2015
To read this article in full you may need to log in, make a payment or gain access through a site license (see right). Oncogene 34 , 2721-2731 (21 May 2015) | doi :10.1038/onc.2014.226 A Patsialou
     Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.